In vivo, targeted germline CD53 deletion protected against Western diet (WD)–induced hepatic inflammatory gene expression, and NASH diet–induced peripheral fat, hepatic lipid accumulation, and insulin intolerance. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.